Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125758111 | 12575811 | 1 | I | 20160711 | 20160720 | 20160720 | EXP | GXJP2016JP001154 | SANDOZ | SHIRO IMAI ET AL.. AN ATTEMPT OF SECOND INDUCTION THERAPY WITH BEV PLUS PAC THERAPY FOR ADVANCED RECURRENT BREAST CANCER. THE 24TH ANNUAL MEETING OF THE JAPANESE BREAST CANCER SOCIETY. 2016;607 | 60.00 | YR | F | Y | 0.00000 | 20160720 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125758111 | 12575811 | 1 | PS | PACLITAXEL INTRAVENOUS INFUSION | PACLITAXEL | 1 | Unknown | Y | 78167 | ||||||||||
| 125758111 | 12575811 | 2 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125758111 | 12575811 | 1 | Breast cancer recurrent |
| 125758111 | 12575811 | 2 | Breast cancer recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125758111 | 12575811 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125758111 | 12575811 | Platelet count decreased | Platelet count decreased |
| 125758111 | 12575811 | Therapy partial responder | |
| 125758111 | 12575811 | Tumour marker increased | Tumour marker increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |